Efficient capital allocation

We have successfully transformed our organisation multiple times on the strength of our efficient allocation of capital across our business portfolio. Ever since we commenced our journey, we have always remained committed towards efficient capital allocation, while undertaking controlled risks, to consistently generate higher profitability and deliver superior shareholder returns.




OVER THE PRECEDING 29 YEARS, MORE THAN 90% OF OUR KEY CAPITAL ALLOCATION DECISIONS TURNED OUT TO BE SUCCESSFUL.

KEY CAPITAL ALLOCATION POST ABBOTT DEAL

Invested ` 24,975 Crores (on B/S) & ` 7,157
Crores (off B/S) in FS

• Average yields on loan
- 16%

• RoE in FS business –
25%+
 

` 4,583 Crores invested in
Shriram Group
 

• Investments strategic in
nature

• Mr. Ajay Piramal is the
Chairman of Shriram Capital (Holdco)

~ ` 6,000 Crores invested in Pharma
 

• 6-Year Revenue CAGR
- 17%

• 7 value accretive
acquisitions in last
2 years

~ ` 4,450 Crores invested in Healthcare Insight & Analytics

• Business, geographic,
currency diversification

• Investing in new
areas i.e. payers and
providers

` 5,228 Crores of capital returned to shareholders
 

• Buyback of ` 2,508 Crores

• Annual dividends of
` 2,116 Crores & Special dividend of ` 604 Crores